Nektar TherapeuticsNKTRNASDAQ
LOADING
|||
Cash Flow Performance
Trending higher, below historical average, strong compound growth.
Left:
||||
Free cash flow yield
Latest
-92.63%
↓ 142% below average
Average (9y)
-38.33%
Historical baseline
Range
High:11.89%
Low:-180.12%
CAGR
+42.7%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -92.63% | +48.6% |
| 2023 | -180.12% | -146.0% |
| 2022 | -73.22% | -324.0% |
| 2021 | -17.27% | -63.6% |
| 2020 | -10.56% | -12.4% |
| 2019 | -9.40% | -179.0% |
| 2018 | 11.89% | +1329.2% |
| 2017 | -0.97% | +86.6% |
| 2016 | -7.21% | -90.9% |
| 2015 | -3.78% | - |